KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 138 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,507,500 | +4.0% | 1,125,000 | +38.9% | 0.86% | +6.2% |
| Q2 2023 | $1,449,900 | +55.3% | 810,000 | +237.5% | 0.80% | +25.0% |
| Q1 2023 | $933,600 | +3.7% | 240,000 | +71.4% | 0.64% | +145.8% |
| Q4 2021 | $900,000 | +13.6% | 140,000 | +2.9% | 0.26% | +30.3% |
| Q3 2021 | $792,000 | -5.8% | 136,000 | +66.9% | 0.20% | -11.8% |
| Q2 2021 | $841,000 | +53.7% | 81,500 | +56.7% | 0.23% | +23.9% |
| Q1 2021 | $547,000 | +108.0% | 52,000 | +205.9% | 0.18% | +67.3% |
| Q4 2020 | $263,000 | – | 17,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |